Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06523218 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory

A NA study of Cognitive Decline and Cognitive Function, sponsored by Scale Media.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06523218 is a NA study of Cognitive Decline and Cognitive Function that is active but no longer recruiting, run by Scale Media. The registered enrollment target is 50 participants, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06523218, a NA study of Cognitive Decline and Cognitive Function, is active but no longer recruiting, sponsored by Scale Media.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the efficacy of 1MD Nutrition's MindMD supplement in improving and maintaining cognitive function and memory. The randomized controlled trial will include 50 healthy participants aged 50-75 years, lasting for 3 months. Participants will be randomized to receive either the test product or a placebo.

Conditions Studied

Cognitive Decline Cognitive Function

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT MindMD Supplement

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-05-17
Est. Completion 2024-08-17
Phase NA

Sponsor

Scale Media

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06523218

The ClinicalTrials.gov registry entry for NCT06523218 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (96% lower). The listed sponsor is Scale Media, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06523218 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06523218 about?

NCT06523218 is a clinical study titled "A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory". This study will evaluate the efficacy of 1MD Nutrition's MindMD supplement in improving and maintaining cognitive function and memory. The randomized controlled trial will include 50 healthy participants aged 50-75 years, lasting for 3 months. Participants will be randomized to receive either the te...

What is the current status of trial NCT06523218?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-05-17. Estimated completion is 2024-08-17.

What conditions does trial NCT06523218 study?

This clinical trial studies the following conditions: Cognitive Decline, Cognitive Function.

What interventions are being tested in trial NCT06523218?

The interventions under investigation include: Placebo (OTHER), MindMD Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06523218?

This trial is sponsored by Scale Media, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06523218 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cognitive Decline

All registered trials for this condition

Cognitive Function

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.